The effects of an incentive program on quality of care in diabetes management
- 30 July 2009
- journal article
- research article
- Published by Wiley in Health Economics
- Vol. 18 (9) , 1091-1108
- https://doi.org/10.1002/hec.1536
Abstract
An incentive program for general practitioners to encourage systematic and igh-quality care in chronic disease management was introduced in Australia in 1999. There is little empirical evidence and ambiguous theoretical guidance on which effects to expect. This paper evaluates the impact of the incentive program on quality of care in diabetes, as measured by the probability of ordering an HbA1c test. The empirical analysis is conducted with a unique data set and a bivariate probit model to control for the self-selection process of practices into the program. The study finds that the incentive program increased the probability of an HbA1c test being ordered by 20 percentage points and that participation in the program is facilitated by the support of Divisions of General Practice. Copyright © 2009 John Wiley & Sons, Ltd.Keywords
This publication has 25 references indexed in Scilit:
- Record rewards: the effects of targeted quality incentives on the recording of risk factors by primary care providersHealth Economics, 2009
- Lessons From Evaluations of Purchaser Pay-for-Performance ProgramsMedical Care Research and Review, 2008
- Physicians’ multitasking and incentives: Empirical evidence from a natural experimentJournal of Health Economics, 2008
- Effects of Paying Physicians Based on their Relative Performance for QualityJournal of General Internal Medicine, 2007
- Mortality, lifestyle and socio-economic statusJournal of Health Economics, 2007
- Physician Compensation from Salary and Quality of Diabetes CareJournal of General Internal Medicine, 2007
- Early Experience With Pay-for-PerformanceJAMA, 2005
- Linking Physicians' Pay to the Quality of Care — A Major Experiment in the United KingdomNew England Journal of Medicine, 2004
- The Alignment and Blending of Payment Incentives within Physician OrganizationsHealth Services Research, 2004
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998